ニュース

Benzinga.com5月

Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls

UBX1325-treated patients saw a mean BCVA gain of +5.5 ETDRS letters at 36 weeks. Unity plans to release full 36-week data for all patients in Q2 2025. Get the strategy to turn September’s volatility ...